Tag Archives: NASDAQ:MTBC

B.Riley FBR Keeps Their Buy Rating on MTBC (MTBC)

B.Riley FBR analyst Marc Wiesenberger reiterated a Buy rating on MTBC (MTBC – Research Report) today and set a price target of $8.00. The company’s shares closed last Monday at $4.75. Wiesenberger has an average return of 9.9% when recommending

H.C. Wainwright Remains a Buy on MTBC Inc (MTBC)

H.C. Wainwright analyst Kevin Dede reiterated a Buy rating on MTBC Inc (MTBC – Research Report) today and set a price target of $6.00. The company’s shares closed last Monday at $4.00. According to TipRanks.com, Dede has 0 stars on

A Director at MTBC Inc (NASDAQ: MTBC) is Selling Shares

Yesterday, a Director at MTBC Inc (MTBC – Research Report), John N. Daly, sold shares of MTBC for $37K. See today’s analyst top recommended stocks >> Based on MTBC Inc’s latest earnings report for the quarter ending June 30, the

A Director at MTBC, Inc. (NASDAQ: MTBC) is Selling Shares

Yesterday, a Director at MTBC, Inc. (MTBC – Research Report), John N. Daly, sold shares of MTBC for $32.24K. See today’s analyst top recommended stocks >> Based on MTBC, Inc.’s latest earnings report for the quarter ending March 31, the

Analysts Are Bullish on These Technology Stocks: MTBC, Inc. (MTBC), Wideopenwest Inc (WOW)

There’s a lot to be optimistic about in the Technology sector as 2 analysts just weighed in on MTBC, Inc. (MTBC – Research Report) and Wideopenwest Inc (WOW – Research Report) with bullish sentiments. MTBC, Inc. (MTBC) In a report

What Did This CEO Just Do with Personal Shares of Medical Transcription Billing (NASDAQ: MTBC)?

Yesterday, the CEO of Medical Transcription Billing (MTBC – Research Report), Stephen Andrew Snyder, sold shares of MTBC for $136.1K. Following Stephen Andrew Snyder’s last MTBC Sell transaction on March 28, 2018, the stock climbed by 1.8%. See today’s analyst